Patient & Caregiver:
CONQUER Type 2 Inflammation

Immune system cells, such as eosinophils and mast cells release inflammatory cytokines that lead to symptoms of diseases like asthma, atopic dermatitis, eosinophil esophagitis, and chronic obstructive pulmonary disease, among others. This is called type 2 inflammation (T2I).

Learn more about T2I and which diseases it causes; how to talk to your doctor about your condition; and why individualized, targeted therapy is such an important part of the treatment approach. Access detailed information for specific type 2 inflammatory conditions through the dedicated community of care portals; high-definition educational animations and additional tools can be found within the HD Visual Learning section.

This activity is provided by Med Learning Group.
This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Copyright © 2025 | Med Learning Group | All Rights Reserved | Website by Divigner

Pin It on Pinterest

Directory
Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers